LGR4 and neoplasm: Moreover, LGR4 knockdown in DU-145 mCRPC cells reduces the transcription of EMT and Wnt target genes, and decreases tumor burden in xenografts, suggesting LGR4 plays an oncogenic role in the prostate by potentiating Wnt signaling and EMT [114].